OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹86 Cr | ₹86 Cr | ₹34 Cr | ₹33 Cr | ₹8.07 Cr |
What is the latest Total Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹86 Cr |
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹8.07 Cr |
How is Total Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹86 Cr | 0.29 | |
| Mar2025 | ₹86 Cr | 154.78 | |
| Mar2024 | ₹34 Cr | 2.42 | |
| Mar2023 | ₹33 Cr | 307.76 | |
| Mar2022 | ₹8.07 Cr | - | |
Compare Total Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹177.6 Cr | -3.3% | -14.3% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.3% |
-14.3% |
-32.1% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses